Pseudomonas Aeruginosa Respiratory Tract Infection clinical trials at UCSF
1 in progress, 1 open to new patients
Safety and Efficacy of 2 Treatment Regimens of Aztreonam for Inhalation Solution in Children With Cystic Fibrosis and New Onset Pseudomonas Aeruginosa Infection
open to eligible people ages 3 months to 18 years
The primary objective of this study is to evaluate the safety and efficacy of a 14-day course versus a 28-day course of aztreonam for inhalation solution (AZLI) in participants with new onset Pseudomonas aeruginosa respiratory tract infection.
San Francisco, California and other locations